How big is the Global STD Diagnostics Market?

The Global STD Diagnostics Market size is expected to reach USD 16.98 billion in 2024 and grow at a CAGR of 7.08% to reach USD 23.91 billion by 2029. Read More

What is the current Global STD Diagnostics Market size?

In 2024, the Global STD Diagnostics Market size is expected to reach USD 16.98 billion. Read More

Who are the key players in Global STD Diagnostics Market?

Abbott Laboratories, Diasorin S.p.A, Hologic, Inc, Siemens AG and Cephied (Danaher Corporation) are the major companies operating in the Global STD Diagnostics Market. Read More

Which is the fastest growing region in Global STD Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global STD Diagnostics Market?

In 2024, the North America accounts for the largest market share in Global STD Diagnostics Market. Read More

What years does this Global STD Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Global STD Diagnostics Market size was estimated at USD 15.86 billion. The report covers the Global STD Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global STD Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global STD Diagnostics Market Share

Statistics for the 2023 & 2024 Global STD Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Global STD Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global STD Diagnostics Industry

The market for STD Diagnostics is moderately competitive in nature. Key players in the STD diagnostics market are Abbott Laboratories, MedMira Inc, Qaigen Inc, Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Diasorin S.p.A, bioMeriuex, Hologic, Inc, Bio-Rad Laboratories, Inc., amongst others. These companies focus on partnership and product/technology licensing opportunities in the sexually transmitted diseases diagnostics industry.